ClariVest Asset Management LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$611,000
+44.8%
60,000
+6.0%
0.02%
+57.1%
Q4 2020$422,000
+62.3%
56,600
-25.1%
0.01%
+55.6%
Q3 2020$260,000
-31.9%
75,600
-5.7%
0.01%
-10.0%
Q2 2020$382,000
+126.0%
80,200
-5.3%
0.01%
+100.0%
Q1 2020$169,000
-70.5%
84,700
-43.9%
0.01%
-61.5%
Q2 2019$572,000
-70.1%
150,998
-35.7%
0.01%
-66.7%
Q1 2019$1,913,000
+2.5%
234,898
+1.6%
0.04%
-2.5%
Q4 2018$1,866,000
+1.0%
231,198
-4.5%
0.04%
+21.2%
Q3 2018$1,847,000
+29.8%
241,998
-2.5%
0.03%
+32.0%
Q2 2018$1,423,000
+1.0%
248,198
-15.9%
0.02%
+4.2%
Q1 2018$1,409,000
+3.4%
295,166
+6.3%
0.02%
+4.3%
Q4 2017$1,363,000
+247.7%
277,567
+271.6%
0.02%
+155.6%
Q3 2017$392,000
+166.7%
74,700
+398.0%
0.01%
+80.0%
Q3 2014$147,000
+104.2%
15,000
+51.5%
0.01%
+66.7%
Q3 2013$72,0009,9000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders